MetLife Investment Management, LLC

Q1 2022 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Israel Grafstein - CCO
Location
Whippany, New Jersey
Holdings as of
March 31, 2022
Value $
$15.4 B
Num holdings
2,727
Date filed
5/10/2024, 03:47 PM
Description
All US holdings of this investor are reported in this report.
Previous filing
Q4 2021 - May 17, 2024
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2022 Q1 - RESTATEMENT compared to 2021 Q4 - RESTATEMENT by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Israel Grafstein CCO Whippany, New Jersey 5/10/2024

This amendment restates the 13F filed for this quarter, as amended by the 13F amendments filed on March 23, 2023 and June 20, 2023, to correct values, share amounts and/or CUSIPs of certain positions. Please note that this 13F Holdings Report filer is affiliated with Metropolitan Life Insurance Company and Provida Pension Fund Administrator who also file 13F Holdings Reports. Each entity files its own 13F Holdings Report because each entity has investment discretion over certain 13(f) securities reported. All three 13F Holdings Report filers are under common control of their ultimate parent, MetLife, Inc., who files a 13F Combination Report.

Other Included Managers (1):

Num Name File Number
1 METLIFE INC 028-18621